AstraZeneca plans to build a manufacturing facility in Qingdao, China, to produce its Breztri aerosol inhalant COPD treatment, which was recently added to the country...

More than a decade after Makena's FDA approval to prevent recurrent preterm birth and two years after the FDA recommended the drug be pulled from the market, Covis Ph...

The FDA is poking holes in Acadia Pharmaceuticals’ second try for expanding Nuplazid into a new neurological disorder—and in doing so, the agency has revealed a chasm...

After an all-day meeting, an FDA advisory committee unanimously voted to recommend Moderna's two-dose COVID-19 vaccine for kids ages 6 to 17. This means an FDA author...

Pfizer launched its first TV commercial for its new psoriasis therapy Cibinqo, and it’s giving us the blues. You may be forgiven for thinking Pfizer had left a ge...

Genentech's campaign song by James Ian, which debuted last November, played at the Olympics closing ceremony this month because of the song's message of inclusivity. ...

Eli Lilly’s commitment to the immunology field has paid off with another important approval for JAK inhibitor Olumiant. And it's an industry first in alopecia areata....

As Almirall looks to ramp up its Klisyri launch, the pharma is organizing an inaugural awareness day for the skin condition it treats. Actinic Keratosis Global Day h...

Hot on the heels of Pfizer’s access accord, GSK’s ViiV Healthcare is teaming up with its old friend the Medicines Patent Pool (MPP) to broaden access to its latest HI...

The ketamine drug delivery deals keep coming. PharmaTher is again involved in the latest agreement, teaming up with CC Biotechnology Corporation (CCBIO) to access a w...